The Filing Desk

AtriCure vs Glaukos

AtriCure ATRC · Glaukos GKOS · Health Care Equipment

AtriCure reported revenue of $534 million in fiscal 2025, about the same as Glaukos' $507 million in fiscal 2025. AtriCure's revenue grew 14.9% in its latest year, and Glaukos' grew 32.3%. AtriCure had an operating margin of -1.8%, against -39.3% at Glaukos. Free cash flow was $48 million at AtriCure and −$22 million at Glaukos.

Side by side

AtriCureGlaukos
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$534M$507M
Revenue growth14.9%32.3%
Revenue growth a year, last 5 years20.9%17.7%
Gross margin75.0%55.7%
Operating margin−1.8%−39.3%
Net margin−2.1%−37.0%
Free cash flow$48M−$22M
Free cash flow margin9.0%−4.4%
Return on capital−1.9%—
Net debt to EBITDA−8.9x—
Dividends and buybacks$0M$0M
Change in diluted share count1.7%8.4%
Last close$56.84$245.72
P/E at the last close189.5×—
Insider trades, last 12 monthssold $4.4 millionsold $80.3 million
Piotroski F-score7 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
AtriCureGlaukos
Operating margin
Percent of revenue
AtriCureGlaukos
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AtriCureGlaukos

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the AtriCure and Glaukos pages.